AdjuCor GmbH news
MUNICH, Germany – August 26th, 2019: After reaching a key milestone towards clinical application with a successful 60 day in-vivo study, AdjuCor announces the closure of a new financing round with Hirschvogel Vermögensverwaltung GmbH, a Bavarian Investor who intends to further expand its activity into the medical device arena.
Hirschvogel Vermögensverwaltung GmbH announces its new investment into the innovative MedTech Company AdjuCor to further develop thei
MUNICH, Germany – February 4th, 2020: In the future, novel polymers should make it possible to individually manufacture artificial elastic tissue replacements for pericardium, heart valves or blood vessels. In the PolyKARD project, biomimetic polymers are being developed that can imitate the mechanical properties of pericardial tissue. Using 3D printing and electrospinning, these polymers will be used to produce tailor-made implants. In addition, a 3D printer that
MUNICH, Germany – October 2nd, 2019: After completing a 60-day pre-clinical study, Professor Stephen Wildhirt, MD, PhD, CEO at AdjuCor, is excited to report on its success. Apart from other achievements, the study confirmed the chronic physiologic acceptance of their non-blood-contacting biventricular cardiac support device by the body.
AdjuCor has previously completed a successful 30-day in vivo study. An in-depth report on the results of the 30 and 60-day trials is